Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages
Delaware is a state located in the Mid-Atlantic region of the United States. It is widely known for its business-friendly regulations and favorable corporate laws. One notable collaboration involving a Delaware Collateral License Agreement is between Gentling, Inc. and The University of North Texas Health Science Center. The Delaware Collateral License Agreement serves as a legal document that outlines the terms and conditions under which Gentling, Inc. is granted collateralized rights and access to certain intellectual property (IP) developed by The University of North Texas Health Science Center. This agreement allows Gentling, Inc. to utilize the center's inventions, patents, and research findings for specific commercial purposes. Keywords: Delaware, Collateral License Agreement, Gentling, Inc., The University of North Texas Health Science Center, intellectual property, collaboration, Mid-Atlantic, United States, business-friendly regulations, corporate laws, commercial purposes, inventions, patents, research findings. Types of Delaware Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center may include: 1. Research and Development (R&D) Collaboration: This type of agreement focuses on joint efforts to further research and develop innovative technologies or products. Gentling, Inc. gains access to the Center's research advancements and expertise to enhance their own R&D capabilities. 2. Exclusive Licensing Agreement: In this type of agreement, Gentling, Inc. is granted exclusive rights to utilize the Center's intellectual property, preventing other companies or entities from accessing or utilizing the same IP for a specific period. This ensures Gentling, Inc.'s competitive advantage in their respective markets. 3. Non-exclusive Licensing Agreement: This agreement grants Gentling, Inc. non-exclusive rights to use the Center's intellectual property, allowing other entities to access and utilize the same IP concurrently. This type of agreement promotes collaboration and fosters innovation within a broader industry context. 4. Royalty Payments: Some Delaware Collateral License Agreements involve the payment of royalties by Gentling, Inc. to The University of North Texas Health Science Center. These royalties serve as compensation to the Center for granting Gentling, Inc. the right to utilize and commercialize their intellectual property. 5. Technology Transfer Agreement: This type of agreement focuses on the transfer of specific technologies developed by the Center to Gentling, Inc. These technologies may include medical devices, drugs, or methods. The agreement outlines rights, responsibilities, and any restrictions related to the technology transfer process. Keywords: Research and Development, Exclusive Licensing Agreement, Non-exclusive Licensing Agreement, Royalty Payments, Technology Transfer Agreement.
Delaware is a state located in the Mid-Atlantic region of the United States. It is widely known for its business-friendly regulations and favorable corporate laws. One notable collaboration involving a Delaware Collateral License Agreement is between Gentling, Inc. and The University of North Texas Health Science Center. The Delaware Collateral License Agreement serves as a legal document that outlines the terms and conditions under which Gentling, Inc. is granted collateralized rights and access to certain intellectual property (IP) developed by The University of North Texas Health Science Center. This agreement allows Gentling, Inc. to utilize the center's inventions, patents, and research findings for specific commercial purposes. Keywords: Delaware, Collateral License Agreement, Gentling, Inc., The University of North Texas Health Science Center, intellectual property, collaboration, Mid-Atlantic, United States, business-friendly regulations, corporate laws, commercial purposes, inventions, patents, research findings. Types of Delaware Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center may include: 1. Research and Development (R&D) Collaboration: This type of agreement focuses on joint efforts to further research and develop innovative technologies or products. Gentling, Inc. gains access to the Center's research advancements and expertise to enhance their own R&D capabilities. 2. Exclusive Licensing Agreement: In this type of agreement, Gentling, Inc. is granted exclusive rights to utilize the Center's intellectual property, preventing other companies or entities from accessing or utilizing the same IP for a specific period. This ensures Gentling, Inc.'s competitive advantage in their respective markets. 3. Non-exclusive Licensing Agreement: This agreement grants Gentling, Inc. non-exclusive rights to use the Center's intellectual property, allowing other entities to access and utilize the same IP concurrently. This type of agreement promotes collaboration and fosters innovation within a broader industry context. 4. Royalty Payments: Some Delaware Collateral License Agreements involve the payment of royalties by Gentling, Inc. to The University of North Texas Health Science Center. These royalties serve as compensation to the Center for granting Gentling, Inc. the right to utilize and commercialize their intellectual property. 5. Technology Transfer Agreement: This type of agreement focuses on the transfer of specific technologies developed by the Center to Gentling, Inc. These technologies may include medical devices, drugs, or methods. The agreement outlines rights, responsibilities, and any restrictions related to the technology transfer process. Keywords: Research and Development, Exclusive Licensing Agreement, Non-exclusive Licensing Agreement, Royalty Payments, Technology Transfer Agreement.